Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ivana Němečkova"'
Autor:
Ivana Nemeckova, Samira Eissazadeh, Jana Urbankova Rathouska, Jan Silhavy, Hana Malinska, Michal Pravenec, Petr Nachtigal
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background C-reactive protein (CRP) is an acute inflammatory protein detected in obese patients with metabolic syndrome. Moreover, increased CRP levels have been linked with atherosclerotic disease, congestive heart failure, and ischemic hea
Externí odkaz:
https://doaj.org/article/64bd60ec726e4193987ffab338abf635
Autor:
Veronica Marin, Natalia Rosso, Matteo Dal Ben, Alan Raseni, Manuela Boschelle, Cristina Degrassi, Ivana Nemeckova, Petr Nachtigal, Claudio Avellini, Claudio Tiribelli, Silvia Gazzin
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0158817 (2016)
Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) are the hepatic manifestations of the metabolic syndrome; worrisome is the booming increase in pediatric age. To recreate the full spectrum of juvenile liver pathology
Externí odkaz:
https://doaj.org/article/8877189aed67467aafe2678a3dc7438d
Autor:
Ivana Nemeckova, Agnieszka Serwadczak, Barbara Oujo, Katerina Jezkova, Jana Rathouska, Petra Fikrova, Michala Varejckova, Carmelo Bernabeu, Jose M Lopez-Novoa, Stefan Chlopicki, Petr Nachtigal
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0119665 (2015)
Increased levels of a soluble form of endoglin (sEng) circulating in plasma have been detected in various pathological conditions related to cardiovascular system. High concentration of sEng was also proposed to contribute to the development of endot
Externí odkaz:
https://doaj.org/article/87c695d80bfc4061b3ae8f0a0b788af6
Autor:
Iveta Nejmanová, Barbora Vitverová, Samira Eissazadeh, Katarina Tripská, Ivone Cristina Igreja Sa, Radomír Hyšpler, Ivana Němečkova, Miguel Pericacho, Petr Nachtigal
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 8, Iss 12, p 173 (2021)
Endoglin is a 180 kDa transmembrane glycoprotein that was demonstrated to be present in two different endoglin forms, namely membrane endoglin (Eng) and soluble endoglin (sEng). Increased sEng levels in the circulation have been detected in atheroscl
Externí odkaz:
https://doaj.org/article/fb45bfcea7f44f50866f1ed99d6668e0
Autor:
Nachtigal, Iveta Nejmanová, Barbora Vitverová, Samira Eissazadeh, Katarina Tripská, Ivone Cristina Igreja Sa, Radomír Hyšpler, Ivana Němečkova, Miguel Pericacho, Petr
Publikováno v:
Journal of Cardiovascular Development and Disease; Volume 8; Issue 12; Pages: 173
Endoglin is a 180 kDa transmembrane glycoprotein that was demonstrated to be present in two different endoglin forms, namely membrane endoglin (Eng) and soluble endoglin (sEng). Increased sEng levels in the circulation have been detected in atheroscl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::df8cb9560a5cfe16feca8e24a57e2c4b